Clinical Trials Browser

Completed × Prostatic Neoplasms × pertuzumab × Clear all

NCT05730712 2026-02-06

Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00058539 2015-06-23

Safety and Efficacy Study of Pertuzumab to Treat Castration-Resistant Prostate Cancer

Phase 2 Completed

42 enrolled 10 charts

Prostatic Neoplasms